paxilline has been researched along with myricetin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, S; Jung, DH; Kim, CS; Kim, J; Kim, JS; Kim, KM; Kim, YS | 1 |
1 other study(ies) available for paxilline and myricetin
Article | Year |
---|---|
Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1/2, FAK-1, and paxillin in vitro and in vivo.
Topics: Animals; Cattle; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Flavonoids; Focal Adhesion Kinase 1; Glycation End Products, Advanced; Intravitreal Injections; Male; MAP Kinase Signaling System; Paxillin; Pericytes; Phosphorylation; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine | 2015 |